Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIA Study of Subcutaneous 5-aza-2'- Deoxycytidine (Decitabine) in Patients With Thalassemia Intermedia

NCT00661726 is registered in ClinicalTrials.gov with Carelon Research as lead sponsor.

NCT NCT00661726
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00661726 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIA Study of Subcutaneous 5-aza-2'- Deoxycytidine (Decitabine) in Patients With Thalassemia Intermedia
Lead sponsor
Carelon Research
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2008
Completion date
September 30, 2010
Enrollment
6 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

thalassemia